FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972494611> ?p ?o ?g. }

• W1972494611 endingPage "850" @default.
• W1972494611 startingPage "846" @default.
• W1972494611 abstract "To assess the efficacy of intravitreal triamcinolone treatment for macular edema from central retinal vein occlusion (CRVO) and hemiretinal vein occlusion (HRVO).This study was a retrospective medical records review of 24 eyes of 24 patients (mean age, 71 years) that were injected with 4 mg of intravitreal triamcinolone acetonide for treatment of macular edema due to CRVO (n = 21) and HRVO (n = 3). Of the 24 eyes, 14 were injected once, 6 were injected twice, 3 were injected 3 times, and 1 received 4 injections. Mean follow-up time was 10 months (range, 3-24 months). The average time between onset of symptoms and first injection was 5.4 months (range, 2-48 months). Available documents on pre- and postinjection optical coherence tomography central foveal thickness in 23 of 39 total injections were evaluated.All injections resulted in reduction in central foveal thickness as determined by optical coherence tomography. The mean central foveal thickness decreased to 55% of preinjection values ([n = 23] 635 vs. 352 mum, respectively; P < 0.001). The average gain in visual acuity was 1.3 Snellen lines (range, -3-7) over the course of the study period. Ten eyes gained > or =2 lines of visual acuity, 3 eyes improved 1 line, 7 eyes remained the same, and 4 eyes worsened. There was no correlation between improvement in foveal thickness and corresponding visual gain (P = 0.24). None of the eyes of diabetic patients (n = 6) or patients with ischemic CRVO (n = 2) improved in visual acuity. The difference in mean baseline (20/167) and mean final visual acuity (20/91) was statistically significant (P = 0.015). The mean best postinjection visual acuity (20/67) was also significantly higher than the mean final visual acuity (P = 0.019). When diabetic and ischemic CRVO patients were excluded, the difference between mean baseline visual acuity and mean final visual acuity was found to be highly significant ([n = 16] 20/133 vs. 20/67, respectively; P < 0.001), while mean final and best postinjection visual acuities (20/50) did not differ (P = 0.085). Eight of 16 phakic eyes showed progression of cataract, 2 of which underwent cataract extraction. Nine of 18 patients without a history of glaucoma developed ocular hypertension and required glaucoma medication during postinjection follow-up. Trabeculectomy was performed on two eyes with glaucoma. Two other eyes developed epiretinal membranes, one of which underwent vitrectomy.Intravitreal triamcinolone may be effective in treating macular edema from CRVO and HRVO. Subjects with concurrent diabetes or ischemic central retinal vein were less likely to have visual improvement." @default.
• W1972494611 created "2016-06-24" @default.
• W1972494611 creator A5001955812 @default.
• W1972494611 creator A5024774995 @default.
• W1972494611 creator A5030166954 @default.
• W1972494611 creator A5034104351 @default.
• W1972494611 creator A5036585007 @default.
• W1972494611 creator A5045200129 @default.
• W1972494611 creator A5060033251 @default.
• W1972494611 creator A5060766981 @default.
• W1972494611 creator A5085581185 @default.
• W1972494611 date "2005-10-01" @default.
• W1972494611 modified "2023-09-27" @default.
• W1972494611 title "INTRAVITREAL TRIAMCINOLONE TREATMENT FOR MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION AND HEMIRETINAL VEIN OCCLUSION" @default.
• W1972494611 cites W1898187276 @default.
• W1972494611 cites W1987853542 @default.
• W1972494611 cites W1996285641 @default.
• W1972494611 cites W2002936633 @default.
• W1972494611 cites W2085681324 @default.
• W1972494611 cites W2087355096 @default.
• W1972494611 cites W2106794880 @default.
• W1972494611 cites W2110175853 @default.
• W1972494611 cites W2141585838 @default.
• W1972494611 cites W2168858270 @default.
• W1972494611 cites W2287479431 @default.
• W1972494611 cites W2993769995 @default.
• W1972494611 cites W4233012843 @default.
• W1972494611 cites W4235001346 @default.
• W1972494611 doi "https://doi.org/10.1097/00006982-200510000-00005" @default.
• W1972494611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16205562" @default.
• W1972494611 hasPublicationYear "2005" @default.
• W1972494611 type Work @default.
• W1972494611 sameAs 1972494611 @default.
• W1972494611 citedByCount "76" @default.
• W1972494611 countsByYear W19724946112012 @default.
• W1972494611 countsByYear W19724946112013 @default.
• W1972494611 countsByYear W19724946112014 @default.
• W1972494611 countsByYear W19724946112015 @default.
• W1972494611 countsByYear W19724946112016 @default.
• W1972494611 countsByYear W19724946112017 @default.
• W1972494611 countsByYear W19724946112018 @default.
• W1972494611 countsByYear W19724946112020 @default.
• W1972494611 countsByYear W19724946112022 @default.
• W1972494611 countsByYear W19724946112023 @default.
• W1972494611 crossrefType "journal-article" @default.
• W1972494611 hasAuthorship W1972494611A5001955812 @default.
• W1972494611 hasAuthorship W1972494611A5024774995 @default.
• W1972494611 hasAuthorship W1972494611A5030166954 @default.
• W1972494611 hasAuthorship W1972494611A5034104351 @default.
• W1972494611 hasAuthorship W1972494611A5036585007 @default.
• W1972494611 hasAuthorship W1972494611A5045200129 @default.
• W1972494611 hasAuthorship W1972494611A5060033251 @default.
• W1972494611 hasAuthorship W1972494611A5060766981 @default.
• W1972494611 hasAuthorship W1972494611A5085581185 @default.
• W1972494611 hasConcept C118487528 @default.
• W1972494611 hasConcept C141071460 @default.
• W1972494611 hasConcept C2776268601 @default.
• W1972494611 hasConcept C2778257484 @default.
• W1972494611 hasConcept C2778844676 @default.
• W1972494611 hasConcept C2778903070 @default.
• W1972494611 hasConcept C2780347916 @default.
• W1972494611 hasConcept C2780827179 @default.
• W1972494611 hasConcept C2908732032 @default.
• W1972494611 hasConcept C30181142 @default.
• W1972494611 hasConcept C71924100 @default.
• W1972494611 hasConceptScore W1972494611C118487528 @default.
• W1972494611 hasConceptScore W1972494611C141071460 @default.
• W1972494611 hasConceptScore W1972494611C2776268601 @default.
• W1972494611 hasConceptScore W1972494611C2778257484 @default.
• W1972494611 hasConceptScore W1972494611C2778844676 @default.
• W1972494611 hasConceptScore W1972494611C2778903070 @default.
• W1972494611 hasConceptScore W1972494611C2780347916 @default.
• W1972494611 hasConceptScore W1972494611C2780827179 @default.
• W1972494611 hasConceptScore W1972494611C2908732032 @default.
• W1972494611 hasConceptScore W1972494611C30181142 @default.
• W1972494611 hasConceptScore W1972494611C71924100 @default.
• W1972494611 hasIssue "7" @default.
• W1972494611 hasLocation W19724946111 @default.
• W1972494611 hasLocation W19724946112 @default.
• W1972494611 hasOpenAccess W1972494611 @default.
• W1972494611 hasPrimaryLocation W19724946111 @default.
• W1972494611 hasRelatedWork W1972494611 @default.
• W1972494611 hasRelatedWork W2000573532 @default.
• W1972494611 hasRelatedWork W2002936633 @default.
• W1972494611 hasRelatedWork W2041448642 @default.
• W1972494611 hasRelatedWork W2069287335 @default.
• W1972494611 hasRelatedWork W2069330755 @default.
• W1972494611 hasRelatedWork W2146028782 @default.
• W1972494611 hasRelatedWork W2368356977 @default.
• W1972494611 hasRelatedWork W2382102615 @default.
• W1972494611 hasRelatedWork W3031005433 @default.
• W1972494611 hasVolume "25" @default.
• W1972494611 isParatext "false" @default.
• W1972494611 isRetracted "false" @default.
• W1972494611 magId "1972494611" @default.
• W1972494611 workType "article" @default.